<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-PN40107PW</udiDi>
    <basicUdiDi>B-PN40107PW</basicUdiDi>
    <tradeName>Revanesse® Pure™ + with Lidocaine  1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40107</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.486Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40110PK</udiDi>
    <basicUdiDi>B-PN40110PK</basicUdiDi>
    <tradeName>Revanesse® Contour  1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40100</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.472Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40111PM</udiDi>
    <basicUdiDi>B-PN40111PM</basicUdiDi>
    <tradeName>Revanesse® Contour™ + with Lidocaine 1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40111</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.460Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40112PP</udiDi>
    <basicUdiDi>B-PN40112PP</basicUdiDi>
    <tradeName>Revanesse® Kiss   1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40112</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.448Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40113PR</udiDi>
    <basicUdiDi>B-PN40113PR</basicUdiDi>
    <tradeName>Revanesse® Kiss™ + with Lidocaine 1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40113</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.438Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40114PT</udiDi>
    <basicUdiDi>B-PN40114PT</basicUdiDi>
    <tradeName>Revanesse® Revise   1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40114</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.427Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40115PV</udiDi>
    <basicUdiDi>B-PN40115PV</basicUdiDi>
    <tradeName>Revanesse® Outline™ + with Lidocaine  1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40115</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.415Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40116PX</udiDi>
    <basicUdiDi>B-PN40116PX</basicUdiDi>
    <tradeName>Revanesse® Shape  1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40116</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.404Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40125PY</udiDi>
    <basicUdiDi>B-PN40125PY</basicUdiDi>
    <tradeName>Revanesse Contour XL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.390Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40139QB</udiDi>
    <basicUdiDi>B-PN40139QB</basicUdiDi>
    <tradeName>Revanesse® Revise™ + with Lidocaine  1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40139</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.376Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40141PW</udiDi>
    <basicUdiDi>B-PN40141PW</basicUdiDi>
    <tradeName>Revanesse® Outline 1.0 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40141</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.364Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40142PY</udiDi>
    <basicUdiDi>B-PN40142PY</basicUdiDi>
    <tradeName>Revanesse® Outline  1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40142</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.351Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40143Q2</udiDi>
    <basicUdiDi>B-PN40143Q2</basicUdiDi>
    <tradeName>Revanesse® Outline™ + with Lidocaine 1.0 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40143</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.339Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40145Q6</udiDi>
    <basicUdiDi>B-PN40145Q6</basicUdiDi>
    <tradeName>Revanesse Outline</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40145</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.329Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40146Q8</udiDi>
    <basicUdiDi>B-PN40146Q8</basicUdiDi>
    <tradeName>Revanesse Oultine 1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40146</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.319Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40147QA</udiDi>
    <basicUdiDi>B-PN40147QA</basicUdiDi>
    <tradeName>Revanesse® Outline+ 1.0 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40147</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.306Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40148QC</udiDi>
    <basicUdiDi>B-PN40148QC</basicUdiDi>
    <tradeName>Revanesse Outline+ 1.2 mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40148</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:56:41.288Z</lastUpdated>
  </row>
</eudamedExport>